Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics Industry

Denise Dajles, DEng, MSc, the new president and CEO of Cytrellis Biosystems, Inc., hopes to bring a fresh vision to the aesthetics industry, aiming to redefine standards through innovative solutions and collaborative partnerships.

"At Cytrellis, we are a very unique company with a very unique technology. We are truly the first and only treatment that's designed for removing skin," Dajles explained. "With our proprietary Micro-Coring technology, we are sure that we can offer a great outcome to a lot of people who have this concern."

A Collaborative Vision for Aesthetics

Dajles highlighted the importance of bridging the gap between surgical and non-surgical solutions while driving innovation. "As I mentioned, I've been in the aesthetic space for a long time, mostly in the surgical space, and now it's really exciting to bridge that gap. Going from surgery to performing non-surgical procedures, but almost with similar outcomes," she said.

Dajles also emphasized the need for collaboration within the industry, noting that Cytrellis is committed to listening to clinicians and patients to refine its offerings.

"We want to be a company that's easiest to work with, where everybody feels heard, where we get that feedback, where we incorporate that feedback," she said. "We work with our industry partners and our practices in order to make sure we provide the most innovative technology and the best outcomes for everybody."

Driving Growth and Innovation

While Cytrellis’ flagship ellacor system remains a cornerstone, Dajles envisions expanding the company's impact across new indications and markets.

"What we're seeing with ellacor is that the possibilities are huge," she explained. "Right now, we are treating the face—mid to low face. We're treating fine lines, wrinkles, and sagging skin, but we are seeing our practitioners and our physicians do procedures in other places on the body. And we have sagging skin all over, and we are truly the best alternative to remove that sagging skin."

Dajles also recognizes the potential for Cytrellis technology to address emerging trends, such as the demand for minimally invasive treatments among patients experiencing sagging skin due to GLP-1-associated weight loss.

"These are patients who are looking for minimally invasive alternatives to remove their sagging skin. We feel like we can have an important offering there," she said.

A Transformative Approach to Leadership

Under Dajles’ leadership, Cytrellis aims to redefine the aesthetics industry’s approach to innovation and patient care.

"We want to offer the opportunity to age naturally, but also have natural results that just give us a sense of confidence and make us feel and look our best," Dajles said.

With a focus on collaboration, growth, and delivering meaningful results, she is committed to leading Cytrellis into its next chapter.

"We look forward to partnering. We look forward to hearing from all of the clinicians—the dermatologists, the plastic surgeons, everybody who is in this space—because we are willing to learn together, work together, and continue to change the aesthetic industry together with revolutionary and groundbreaking technologies," Dajles said.